COVID-19 patients who suffer a cardiac arrest either in or out of hospital are far more likely to die than patients who are not infected with the coronavirus.
View More People infected with COVID-19 have a higher risk of dying after a cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation
The American College of Cardiology (ACC) and the American Heart Association (AHA) ended 2020 by publishing updated guidance on the management of valvular heart disease. This document covered significant ground with regards to transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair.
View More 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
The National Institute for Health and Care Excellence (NICE) has today published a report highlighting progress made by the health and care system in implementing…
View More NICE report on the impact cardiovascular disease management
“Even before the COVID-19 pandemic, air pollution was an issue of growing concern due to its impact on people’s health, although it was frequently overlooked…
View More Leading cardiovascular organisations call for urgent action to reduce air pollution
Emer Joyce speaks about the impact COVID-19 has had on the clinical landscape of acute cardiac, intensive care and cardiomyopathy/heart failure services including the wide spectrum…
View More COVID‐19, myocarditis, and the other side of the bed
Read the BSH position statement on the roll out of COVID-19 vaccinations The BSH has recently released a statement regarding COVID-19 vaccinations. The statement advises:…
View More BSH position statement on the roll out of COVID-19 vaccinations
The Heart Rhythm Society recently published information regarding an important public health issue concerning the newer generation iPhone 12 which can potentially inhibit lifesaving therapy…
View More Possible inhibition of ICD therapies by newer generation iPhone 12
In 2020, new clinical practice guidelines were published by the European Society of Cardiology. The BCS Clinical Standards Group has reviewed the guidelines and written…
View More BCS Review of ESC Clinical Practice Guidelines: 2020
Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
The following two articles explore the roles social media can play in the cardiovascular sector. From research, to peer-to-peer engagement to recruitment. Social media in…
View More The Expanding Role of Social Media in Cardiovascular Work